Synta Pharmaceuticals Corp. (SNTA) Message Board
-
Gawd I hope it goes to $1.60. That way I can buy a boat load more at an even better price. Keep shortin Reg.
-
Poor old Reggie...still can't get over you losses. Remember Reggie...don't risk that, that you can't afford to lose. Maybe penny slots at the casino is more your speed.
- Reply to
Question. Has anyone on this board sold ESA's, as I have?
by crewrider61 •Apr 1, 2013 12:38 PMNot short or long yet, or a loser as you appear to be. If the trials are double blind , how did the patient,or you, know whether he or she was in the treatment or control arm. Your foolish, emotion filled rant tells me you are underwater. Please don't respond to any more of my posts especially when I ask for intelligent input.
- Reply to
Question. Has anyone on this board sold ESA's, as I have?
by crewrider61 •Apr 1, 2013 12:38 PMAlso, are the ESA's studied all one product or a mix of EPO derivatives? Long acting and short acting? Cost of each?
-
The 37 percent reduction is not that impressive...13k down to 10k IU's. For instance the unites given of EPO for the average oncology patients is 40K IU's. The dialysis market is different I know, but that little reduction is not going to impress the Nephs much, they are still going to have to treat with growth factors. Also, the p-value of 0.034 in that small study is also not too impressive, as a larger study usually dilutes the p-values of small studies. Just playing devils advocate. Anyone with intelligent input please respond. Cost analysis would be good to see.
-
Phishie...are you short?
-
April? Hahaha! How about by noon?
-
Wish I had more
-
-
Really doubted this damn company from the start. Stupid, stupid, stupid! Oh well, I wasn't that deep anyway. Just #$%$ I didn't listen to mt brain weeks ago.
-
Could be another CRL.
-
-
Just followed his slim trail. I am not an idiot. The first stock I followed was DNDN. Made $350k doing the opposite of what he recommended . The guy is a farce.
-
Followed him for 36 months in biotechs. His record was horrible, yet he still has a show and a following. CNBC is also a joke!
- Reply to
Has the company answered or corrected all issues within the CRL?
by crewrider61 •Mar 8, 2013 8:04 AMHello? Anyone? How about just one reference, to just one issue, being resolved to FDA satisfaction. I really do want to buy, but have found no assurances of reconsiliation of issues except for the syring.
-
Can anyone tell me, with references, if this company has actaully addressed all the issues? I'd hate to witness another DSCO.
-
There are people moving into DNDN for a reason. I've been in DNDN for 7 years. We never get the information before it leaks. Oh well, good luck to all longs and keep the faith..
-
I am long, but think that is a bad sign. Anyone know what fund divested or might have divested?
-
15k at $0.44. Holding until $12.00
- Reply to
Q4 in line.....but what will it take for this company to make money?!?!?
by reggie_212 •Feb 27, 2013 7:56 PMWhy do you keep asking the same question? Here is the answer to your question of "What will it take for this company to make money? The answer is 3 more months...or this quarter.